(New York, NY, 21 January 2014) Wolters Kluwer Health today announced it has extended its global distribution agreement with the New England Journal of Medicine (NEJM.org), the leading publisher of breakthrough biomedical research and best practices in clinical medicine, to be the exclusive provider of NEJM site licenses in China. Under terms of the new agreement, Ovid, part of Wolters Kluwer Health, will be the exclusive provider of NEJM site licenses in China providing access to content upon publication on either Ovid or NEJM.org platforms as well as access to the NEJM archive on NEJM.org.
Read the news here.
